BackgroundCheck.run
Search For

Jonathan H Fang, 401712 Robin Ln, Glenview, IL 60025

Jonathan Fang Phones & Addresses

1712 Robin Ln, Glenview, IL 60025    847-9029683   

Chicago, IL   

1336 Central Ave, Wilmette, IL 60091    847-2513165   

Plano, TX   

San Francisco, CA   

Social networks

Jonathan H Fang

Linkedin

Work

Company: National bankruptcy services - Richardson, TX Nov 2012 Position: Accounting associate

Education

School / High School: Rosalind Franklin University of Medicine and Science / Chicago Medical School 2011

Languages

English

Mentions for Jonathan H Fang

Career records & work history

Medicine Doctors

Jonathan Fang Photo 1

Dr. Jonathan H Fang, Hometown IL - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
4140 Southwest Hwy, Hometown, IL 60456
708-4225700 (Phone) 708-4228225 (Fax)
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 2011
Jonathan Fang Photo 2

Jonathan Hwa Fang

Specialties:
Family Medicine
Jonathan Fang Photo 3

Jonathan Hwa Fang, Hometown IL

Specialties:
Family Physician
Address:
4140 Southwest Hwy, Hometown, IL 60456

Jonathan Fang resumes & CV records

Resumes

Jonathan Fang Photo 38

Jonathan Fang

Jonathan Fang Photo 39

Jonathan Fang - Carrollton, TX

Work:
National Bankruptcy Services - Richardson, TX Nov 2012 to May 2013
Accounting Associate
Robertson, Griege & Thoele - Dallas, TX Jan 2012 to Sep 2012
Bookkeeper /Accounts Payable
Homelegance Furniture Outlet Mar 2011 to Jan 2012
Bookkeeper/Accounts Receivable /Inventory Support
Education:
University of Texas at Dallas - Richardson, TX Aug 2010
Master of Science in Taxation
University of Texas at Dallas - Richardson, TX Dec 2008
Bachelor of Science in Accounting

Publications & IP owners

Us Patents

Inhalable Liposomal Sustained Release Composition For Use In Treating Pulmonary Diseases

US Patent:
2023008, Mar 23, 2023
Filed:
Nov 22, 2022
Appl. No.:
17/992481
Inventors:
- Taipei City, TW
Jonathan Fang - South San Francisco CA, US
Yu-Cheng Tseng - Taipei City, TW
Ting-Yu Cheng - Taipei City, TW
Wan-Ni Yu - Taipei City, TW
Jo-Hsin Tang - Taipei City, TW
International Classification:
A61K 9/00
A61K 9/127
A61K 31/496
A61K 47/20
Abstract:
Provided is a liposomal sustained-release composition for use in treatment of pulmonary disease. The liposomal sustained release composition comprises a liposome that includes a polyethylene glycol (PEG)-modified lipid and encapsulates a tyrosine kinase inhibitor. Tyrosine kinase inhibitor is stably entrapped in the liposome, and the resulting liposomal drug formulation can be aerosolized or nebulized for administration via inhalation. This aerosolized liposomal drug formulation yields consistent pharmacokinetic and pharmacodynamic profiles while achieving desired efficacy and safety.

Sustained-Release Pharmaceutical Compositions Comprising An Immunomodulating Agent And Uses Thereof

US Patent:
2021039, Dec 23, 2021
Filed:
Oct 15, 2019
Appl. No.:
17/285623
Inventors:
- Taipei City, TW
- South San Francisco CA, US
Jonathan FANG - South San Francisco CA, US
Hao-Wen KAO - South San Francisco CA, US
Yi-Yu LIN - South San Francisco CA, US
International Classification:
A61K 9/127
A61K 31/137
A61K 47/24
A61K 47/28
A61K 47/02
A61K 31/4245
A61K 47/26
A61K 47/36
Abstract:
The present invention relates to a pharmaceutical composition comprising at least one liposome and a therapeutic agent for treating an auto-immune disease with a high therapeutic agent to lipid ratio and a high encapsulation efficiency. The pharmaceutical composition improves the pharmacokinetic profile and sustains the release of the therapeutic agent. Also provided is the method for treating an auto-immune disease using the pharmaceutical composition disclosed herein.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.